Cannabis
DTx Producer Entheo Digital Will Present at the July Psychedelic Capital Event, Hosted by Microdose
Austin, Texas–(Newsfile Corp. – July 28, 2021) – On Thursday, July 29th, newly founded Digital Therapeutics company will be giving a presentation at Microdose’s Psychedelic Capital Event. Presenting will be the two founding executives Robin Arnott (CEO) and Lyle Maxson (CSO).
“Psychedelic Therapy is the most important movement in mental health right now, and it’s coming at a truly critical moment. These medicines are necessary to support massive psychological healing,” says Robin Arnott, CEO of Entheo Digital. “We’ve been developing SoundSelf as a tool for psychedelic work for years. Now that the world is opening up to psychedelic therapy, we’re ready to support the therapists on the front lines to prepare their clients for deep healing.”
Arnott and Maxson will be sharing insights into the powerful role that digital experiences, or “technodelics,” can play in psychedelic healing.
To watch their session, tune in to Psychedelic Capital on Thursday, July 29th at 1pm Pacific. You can use the code “ENTHEODIGITAL” for a free ticket.
For more information, or to arrange an interview, please contact:
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/91489
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis4 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
SCHWAZZE5 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Humboldt4 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis4 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 days ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III